ABOUT US

News Release

​2021. 1.29 

Journal of Biological Chemistry paper examines enhancement of immunity to coronaviruses through nutritional and pharmacological interventions that enhance NAD levels

MIRAILAB’s work on the potential effectiveness of NMN in fighting COVID-19 and other viral infections takes inspiration in part from this paper, published on October 13, 2020. The coenzyme NAD is essential in all cells, and since NMN is an essential component of NAD, it may therefore have a role in fighting infection though the potential nutritional and pharmacological agency described in the paper.

 

2021. 1.27 
MIRAILAB BIOSCIENCE President and CEO Megumi Tanaka donates to Washington University School of Medicine in St. Louis for fiscal year 2021 through the Tanaka Fund. The donation will be used for a wide range of activities, including research and training of scientists for NMN research.

2021. 1. 1
 A message from our CEO

2021. 1. 1
Change of company name from Shinkowa Pharmaceutical Co., Ltd., to MIRAILAB BIOSCIENCE Inc.

Corporate Data

Company Name:      MIRAILAB BIOSCIENCE Inc.

Founded:                October 2016

Headquarters:          2-30-11, Shinkawa, Chuo-ku, Tokyo, Japan

Kanagawa branch:         2-13-22, 1F, Higashi Kaigan Minami, Chigasaki, Kanagawa, Japan

Kobe branch:                  7th floor Kobe KIMEC Center Building, Minamimachi, Minatojima, Chuo-ku, Kobe, Hyogo, Japan

 

Research Center:           Ginza research center (Life Science Lab) Tokyo, Japan

 

Capital:                            JPY 20,000,000

 

CEO:                                Megumi Tanaka

Research partner:         Hiroaki Kitano, Ph.D. President, The Systems Biology Institute (SBI)

Medical Advisor:            Yo-ichi Nabeshima, M.D., Ph.D. Director, Foundation for Biomedical Research and Innovation at Kobe

Advisors:                         Osamu Kimura           

Business Overview:
-Biotechnology research.

-Development, manufacture, & sales of nutraceuticals (health food & cosmetics)

-Manufacture and sales of pharmaceutical products.

-Manufacture and sales of medical equipment and materials for medical use.

-Management consulting business.

-Import, export, & sales of domestic & foreign goods.

 

Major customers:       Research institutes, domestic and overseas companies and platforms

 

Affiliate companies:   Mirailab USA, Hakushindo Pharmaceutical Co., Ltd.

History

April 2015

Started selling NMN nutraceutical sales begins through Shinkowa Trading Co., Ltd.

 

December 2015

Change of company name from Shinkowa Trading Co., Ltd., to Shinkowa Pharmaceutical Co., Ltd.

 

July 2019

Inauguration of our in-house NMN research facility, Life Science Lab, located at 2-3-11 Nihonbashi Honcho, Chuo-ku, Tokyo, Japan (B11st basement floor of Nihonbashi Life Science Building.)

 

September 2020

Inauguration of our Kobe branch in collaboration with the Institute for Research on Productive Aging (IRPA, located on the 7th floor of the Kobe KIMEC Center Building (Minamimachi, Minatojima, Chuo-ku, Kobe, Japan.), in collaboration with the Institute for Research on Productive Aging (IRPA.)

 

January 2021

Change of company name from Shinkowa Pharmaceutical Co., Ltd., to MIRAILAB BIOSCIENCE Inc.

July 2021

Inauguration of our in-house NMN research facility, Life Science Lab, located at 1-14-4, 6F, Prairie Ginza Bldg ., Tokyo, 104-0061, Japan  (Ginza Life Science Building)

 
grass.jpeg

NOW MAKE NEXT

The MIRAILAB BIOSCIENCE mission is to improve the well-being of our customers and society through rigorous development of productive aging science.

 

In about 40 years, the world population will exceed 10 billion, while the elderly in developed regions will reach 27.6% of the population amid declining birth rates.

 

The arrival of a “super-aging” society is becoming an issue not only in Japan but worldwide.

 

And Japan, with its aging population already exceeding 28%, is now faced with a new challenge: how to extend healthy life expectancy while absolute life expectancy is increasing due to advances in medical technology.

 

In light of this, MIRAILAB BIOSCIENCE is developing NMN-based nutraceuticals, inspired by the potential discovered in the early research of pioneering scientists and motivated by positive results in clinical trials and the feedback of our customers.

 

How far can science expand the possibilities of humankind?

How well can we reflect the benefits of science in our lives?

MIRAILAB BIOSCIENCE Inc. aspires to a new level of Quality Of Life.